Q1 2019 BioCryst Pharmaceuticals Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the BioCryst First Quarter 2019 Earnings Conference Call. (Operator Instructions)
As a reminder, this conference call is being recorded.
I will now like to introduce your host for today's conference, Mr. John Bluth, Senior Vice President of Investor Relations and Corporate Communications. Sir, you may begin.
Thank you, Ashley. Good morning and welcome to BioCryst First Quarter 2019 Corporate Update and Financial Results Conference Call. Today's press release and accompanying slides are available on our website. Participating with me today are CEO, Jon Stonehouse; Chief Medical Officer, Dr. Bill Sheridan; CFO, Tom Staab; and Chief Commercial Officer, Lynne Powell. Following our remarks, we'll answer your questions.
Before we begin, I want to direct your attention to Slide 2, which discusses our use of forward-looking statements and potential risk factors regarding an investment in BioCryst. As
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |